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Abstract The adrenomedullary hormone epinephrine
transduces environmental stressors into cardiovascular
events (tachycardia and hypertension). Although the epi-
nephrine biosynthetic enzyme PNMT genetic locus dis-
plays both linkage and association to such traits, genetic
variation underlying these quantitative phenotypes is not
established. Using an integrated suite of computational and
experimental approaches, we elucidate a functional mech-
anism for common (minor allele frequencies[30%)
genetic variants at PNMT. Transcription factor binding
motif prediction on mammalian PNMT promoter align-
ments identiﬁed two variant regulatory motifs, SP1 and
EGR1, disrupted by G-367A (rs3764351), and SOX17
motif created by G-161A (rs876493). Electrophoretic
mobility shifts of approximately 30-bp oligonucleotides
containing ancestral versus variant alleles validated the
computational hypothesis. Queried against chromafﬁn cell
nuclear protein extracts, only the G-367 and -161A alleles
shifted. Speciﬁc antibodies applied in electrophoretic gel
shift experiments conﬁrmed binding of SP1 and EGR1 to
G-367 and SOX17 to -161A. The in vitro allele-speciﬁc
binding was veriﬁed in cella through promoter reporter
assays: lower activity for -367A haplotypes cotransfected
by SP1 (p = 0.002) and EGR1 (p = 0.034); and enhanced
inhibition of -161A haplotypes (p = 0.0003) cotransfected
with SP1 ? SOX17. Finally, we probed cis/trans regulation
with endogenous factors by chromatin immunoprecipitation
using SP1/EGR1/SOX17 antibodies. We describe the sys-
tematic application of complementary computational and
experimental techniques to detect and document functional
genetic variation in a trait-associated regulatory region. The
results provide insight into cis and trans transcriptional
mechanisms whereby common variation at PNMT can give
rise to quantitative changes in human physiological and
disease traits. Thus, PNMT variants in cis may interact with
nuclear factors in trans to govern adrenergic activity.
Introduction
The enzyme PNMT (phenylethanolamine N-methyltrans-
ferase) catalyzes the synthesis of epinephrine (adrenaline),
providing the only route to formation of this hormone and
neurotransmitter. Variation in the human PNMT promoter
was ﬁrst noted by Wu and Comings (1999) and later sys-
tematically documented in European-American, African-
American, and Japanese populations (Ji et al. 2005; Saito
et al. 2001). Two common PNMT proximal promoter SNPs
are located -367 (rs876493) and -161 (rs3764351) bp
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DOI 10.1007/s00335-010-9253-yupstream of the 50 UTR (untranslated region) (Kaneda et al.
1988), corresponding to -390 and -184 bp upstream of the
translational start (ATG) codon (Sasaoka et al. 1989).
Reported linkage disequilibrium (LD) is high (D0 [0.9)
across the promoter in the HapMap CEU population (Utah
residents with Northern and Western European ancestry
from the Centre d’Etude du Polymorphisme Humain col-
lection) (Frazer et al. 2007; Thorisson et al. 2005).
The Pnmt locus is within the genome-wide conﬁdence
interval for linkage (meiotic cosegregation) with several
stress traits in rodents (http://rgd.mcw.edu/), including salt-
loaded SBP QTL-9, urine volume QTL-18, and cortico-
sterone (glucocorticoid) level QTL-5. Several human dis-
ease associations to PNMT promoter genetic variants have
been documented, including hypertension in African-
Americans (Cui et al. 2003), early-onset Alzheimer’s dis-
ease (Mann et al. 2001), multiple sclerosis (Mann et al.
2002), drug-assisted weight loss (Peters et al. 2003), and
reward dependence temperament (Yamano et al. 2008).
Although two studies failed to ﬁnd association with
hypertension in European (Kepp et al. 2007) and European-
American (Cui et al. 2003) subjects, we observed sex-
dependent association to diastolic blood pressure (Rana
et al. 2007).
Prior PNMT genetic studies have not deﬁnitively iden-
tiﬁed molecular mechanisms whereby genetic variation
may interact with stressors to change PNMT expression. Ji
et al. (2005) compared PNMT promoter haplotype activity,
observing a signiﬁcant decrease in activity for the A.A
(-367.-161) haplotype versus G.G. Extensive work in the
PC12 rat pheochromocytoma cell line suggests orthologous
regulatory motifs for SP1, EGR1, AP2, MAZ, and GRE in
the ﬁrst 1000 base pairs of proximal promoter (Wong and
Tank 2007).
Here we explore regulatory effects of common PNMT
promoter genetic variants (G-367A, G-161A) in cis, as well
as the effects of factors in trans, including SP1 (at G-367A)
and SOX17 (at G-161A), via orthologous motifs in the
human promoter, demonstrating an allele-speciﬁc effect for
SP1 and EGR1 on the G-allele at position-367. Further-
more, we identify a novel allele-speciﬁc inhibitory effect of
SOX17 interacting with SP1 to preferentially inhibit the A
allele at position -161. Sox17 is a transcription factor
involved in development of heart and vascular and lung
tissue (Liao et al. 2009; Liu et al. 2007; Matsui et al. 2006;
Park et al. 2006); all are important targets of the epi-
nephrine-mediated stress response.
Materials and methods
Genomics and luciferase promoter/reporter plasmids
Human PNMT sequence information was obtained at NCBI
(http://www.ncbi.nlm.nih.gov) or UCSC (http://genome.
ucsc.edu) using source clone X52730 (JO3727) (Sasaoka
et al. 1989). Mammalian promoter sequencing and poly-
morphism discovery at the PNMT locus in genomic DNA
were conducted using dideoxy sequencing on an ABI 3100
capillary sequencer (Applied Biosystems, Foster City, CA).
The PNMT promoter regions in chimpanzee (NG06939),
bonobo (NG05253), and rhesus (NG07109) DNA from
Coriell repository samples, as well as rat (strains SHR,
WKY, and BN) samples, were resequenced.
At PNMT, two promoter variants (G-367A and G-161A)
were especially common minor allele frequency[30% (Ji
et al. 2005). The very proximal core promoter (Fig. 1) just
upstream of exon 1, including the TATA box, was invariant;
there were also six G/C-rich stretches, one of which was
disrupted by G-367A. The two common promoter variants
(-367.-161) displayed consistent LD, with D0 approximately
0.90inCaucasians.Ofthefourpossiblepromoterhaplotypes
Fig. 1 Common genetic
variation in the proximal human
PNMT promoter. Common core
promoter motifs (e.g., TATA
box, G/C-rich domains) are
illustrated. The two common
proximal variants (G-367A and
G-161A) are depicted
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123(Ji et al. 2005) at -367.-161, the A.A (at 50.6%) and G.G
(35.1%) were common, while A.G (12.0%) and G.A (1.9%)
wereunusual.Basedonpromoterlocation,highfrequencies,
and LD of promoter variants G-367A and G-161A, we then
focused functional studies on this region.
Human PNMT promoter/luciferase reporter plasmids
were constructed as previously described (Chen et al.
2008). G.G and A.G haplotype fragments corresponding to
PNMT -428 to ?10 bp [with respect to cap site of 23 bp 50
UTR in NCBI source clone X52730 (J03727): 1327-1793,
Chr 17: 35077803-35078242] were ampliﬁed from geno-
mic DNA of known (previously resequenced) promoter
genotype (G.G, 68-year-old black female [#2154]; A.G,
45-year-old Hispanic male [#4261]); these two individuals
did not exhibit other PNMT promoter variants. The hap-
lotype fragments were subcloned by sticky-end ligation
into the upstream promoter site of the pGL3-Basic vector
(Promega Inc., Madison, WI, USA) between XhoI and
KpnI restriction digest sites (New England Biolabs, Ips-
wich, MA, USA). Successful ligations were veriﬁed by
electrophoresis on 1% agarose of 1 lg plasmid digested
overnight with KpnI and XhoI; correct sequence and ori-
entation were veriﬁed by sequencing with RV3 reverse
primer (Promega). G.A and A.A haplotypes (-367.-161)
were generated by site-directed mutagenesis per the man-
ufacturer’s speciﬁcations (QuickChange II; Stratagene, La
Jolla, CA, USA) using the aforementioned G.G and A.G
haplotype plasmids as template and the same oligonu-
cleotide primers as in the electrophoretic mobility shift
assay (EMSA) experiments.
Plasmids were ampliﬁed in DH5-alpha cells (Invitrogen,
Carlsbad, CA, USA), and supercoiled plasmids were
puriﬁed by column adsorption/elution (PureLink HiPure
Plasmid Maxiprep Kit, Invitrogen). Plasmid concentrations
were quantiﬁed by SmartSpec (Bio-Rad, Hercules, CA,
USA) and adjusted to 1.0 lg/ll before transfection.
Cell biology: transient promoter haplotype transfection
and reporter assay
PC12 rat adrenal pheochromocytoma cells were grown in
high-glucose Dulbecco’s modiﬁed Eagle medium supple-
mented with penicillin G (100 U/ml), streptomycin sulfate
(100 mg/ml), 5% fetal bovine serum, and 10% horse serum.
PC12 cells were distributed among 12-well plates and
allowed to reach 60% conﬂuence before transfection. Plas-
mid DNA was incubated in 100 ll per well of serum-free
media with TransfectIN reagent (Bio-Rad) for 15 min and
then added to 400 ll fresh PC12 media. Cells were tran-
siently transfected for 4 h with 1 lg per well haplotype
plasmid or pGL3-Basic vector and then washed with serum-
free media followed by 1 ml PC12 media. Fireﬂy luciferase
activity was measured after 48 h of incubation at 37C, 6%
CO2.Luciferase activity was normalized by total protein per
well measured by Bradford assay (Protein Assay, Bio-Rad)
in a Wallac spectrophotometer. Linear range of protein
concentration was veriﬁed using serial dilutions of bovine
serum albumin (BSA) as a standard. pCMV-driven tran-
scription factor expressing plasmids, including EGR1, AP2,
SOX17, and SP1 plasmids (from Open Biosystems, Hunts-
ville, AL, USA), were cotransfected at0.1 lgper well. Dual
cotransfection of SP1 with SOX17 or SP1 with pcDNA
(pCMV) was also tested at 0.1 lg per well.
PNMT promoter haplotype/luciferase reporter activity
Haplotype luciferase activity (RLU) was normalized to
total protein (Bio-Rad/Bradford Coomassie blue assay at
A595; also background subtracted and divided by volume).
The activity shown in Fig. 3 is the mean activity for four
wells ±1 standard error. In order to compare experiments,
we normalize all values to the empty vector pGL3-Basic
activity. Finally, in order to control for effects of plasmid
cotransfection on promoter activity, we subtract the activ-
ity of the mock cotransfection of the pcDNA3.1 plasmid,
which contains the promoter used to drive transcription
factor expression.
Bioinformatics
Mammalian promoter alignment
Mouse, dog, cat, horse, and cow PNMT sequences were
obtained from http://genome.ucsc.edu (Blanchette et al.
2004; Kent et al. 2002; Kuhn et al. 2009). Due to a gap in
the R. norvegicus reference genome assembly, we also
sequenced the promoter of the WKY rat. Promoter orien-
tation for each sequence was determined by ClustalW
alignment of the exon 1 coding sequence. Promoter
sequences were aligned using ClustalW with a gap penalty
of 100. Phylogenetic trees of the mammals were con-
structed manually using taxonomy information from NCBI.
Prediction of allele-speciﬁc conserved regulatory motifs
We predicted transcription factors with allele-speciﬁc
binding to motifs containing G-367 or G-161A using
phylogenetic footprinting (Wasserman and Sandelin 2004).
Human and rat PNMT promoter sequences were pairwise
aligned using the LAGAN algorithm (Brudno et al. 2003),
as implemented by the CONREAL web server (Berezikov
et al. 2005). Motifs with more than 50% human-rat
homology (length[10 bp) were scored on publicly
available position-weight matrices (PWMs) from JASPAR
(Vlieghe et al. 2006) and TRANSFAC v7.0 (Wingender
et al. 1996) public databases. Motifs scoring greater than
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12380% of maximum in one allele with a difference in score
between alleles were considered positive hits (summarized
in Fig. 2 using SOX17 and SP1 as examples). Results were
cross-veriﬁed using the RAVEN web server (Andersen
et al. 2008), which uses seven-vertebrate PhastCons (Fel-
senstein and Churchill 1996) alignments for identiﬁcation
of conserved motifs. Candidate hits were prioritized for
experimental validation if known to regulate the well-
characterized rat PNMT promoter (Wong and Tank 2007),
or if adrenal, chromafﬁn cell, or PC12 expression activity
in GEO (Edgar et al. 2002) expression array repository was
above 25% of minimum.
Electrophoretic mobility shift assay (EMSA)
Biotinylated double-stranded 29-mer oligonucleotides
(ValueGene, Biotin 30 End DNA Labeling Kit, Pierce,
Rockford, IL, USA) with SNP at position 15 were incu-
bated 45 min and with nuclear extracts of PC12 rat pheo-
chromocytoma cells for 20 min in the presence of 0.1 lg/ll
salmon sperm DNA to minimize nonspeciﬁc binding.
Nuclear extracts were prepared from PC12 cells grown in
10-cm plates by Qproteome Nuclear Protein Kit following
the manufacturer’s speciﬁcations (Qiagen) (Avery-Kiejda
et al. 2008). In separate reactions, either speciﬁc (i.e.,
unlabeled same-allele oligonucleotides) or nonspeciﬁc
competitor (i.e., unlabeled opposite-allele oligonucleo-
tides) was added at 10009 concentration to assay allele-
speciﬁc binding. Antibody assays included 2 ll of antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) in lieu
of competitor oligonucleotide, with nonspeciﬁc IgG as a
negative control). DNA-protein complexes were electro-
phoresed in 5% acrylamide gels for 1 h at 100 V in 0.59
tris-borate ethylene diamine tetra acetic acid (TBE) and
then transferred to nylon membranes at 380 mA in 0.59
TBE and cross-linked with 1200 nm UV light for 1 min.
Complexes were then visualized on X-ray ﬁlm using
horseradish-peroxidase-conjugated streptavidin per the
manufacturer’s protocol (Chemiluminescent Nucleic Acid
Detection Module, Pierce, Rockford, IL, USA) (Matata and
Galinanes 2002; Oltra et al. 2003). Forward/reverse allele-
speciﬁc oligonucleotide probes were as follows (polymor-
phism in lowercase):
-367 A fw: 50-TGAATGGCTGCGGGaGGCTGGAGAA
GAGA-30
-367 A rv: 50-TCTCTTCTCCAGCCtCCCGCAGCCAT
TCA-30
-367 G fw: 50-TGAATGGCTGCGGGgGGCTGGAGA
AGAGA-30
-367 G rv: 50-TCTCTTCTCCAGCCcCCCGCAGCCAT
TCA-30
-161 -367
   G C G G G G G G C T
A  1 2 0 0 0 2 0 0 1 2
C  1 1 0 0 5 0 1 0 1 0
G 4 4 882456  6 0
T  2 1 0 0 1 2 2 2 0 6
   T  C  C A  G  T  G  T  G 
A 7  8  3 30  0  0  0  0  0
C  9 8 18  0  1  0  0  0 17
G  6  4  1 0  0 0 31  2 10
T  9 11  9  1 30 31  0 29  4
HUMAN     tgaatGGCTGCGGGGGG-CTGGAGAagaga
          || | | ||| ||| ||||||||| ||| 
RAT tgga-GTCTGTGGGAGGCTGGAGAGGAGT
ccccaCTCACCTCCAGTGTGTCTGcagcc
|||  | | || |||  | ||| |  || 
CCCTCCCCGCCCCCG-cgCGTCCGTCGCG
HUMAN_G TGAATGGCTGCGGGgGG-CTGGAGAAGAGA
HUMAN_A TGAATGGCTGCGGGaGG-CTGGAGAAGAGA
CHIMP TGAATGGCTGCGGGgGG-CTGGAGAAGAGA
BONOBO TGAATGGCTGCGGGgGG-CTGGAGAAGAGA
RHESUS TGAATGACTGCGGGgGGGCTGGAGAATAGG
MOUSE -----GTCTTTGGGaGG-TTGGAGAGGA--
RAT TGGA-GTCTGTGGGaGG-CTGGAGAGGAGT
DOG ----GCGCC--GGGaGG-CTGGAGGAGAGC
CAT TGAATGGCC-GGGGaG--CTGGAGGAGAGC
HORSE TGAATGGCTGGGGGaG--CTGGAGAAGAGC
COW TGAAT----GCGGGa---CTGGAGAGGGGC
CCCCACTCACCTCCgGTGTGTCTGCAGCC
CCCCACTCACCTCCaGTGTGTCTGCAGCC
CCCCACTCACCTCCgGTGTGTCTGCAGCC
CCCCACTCACCTCCgGTGTGTCTGCAGCC
CCCCCCTCACCTCCgGTGCGTCTGCAGCC
-CCCCCCACGCCCCcGCGCGTCTGTTGCT
-CCCTCCCCGCCCCcGCGCGTCCGTCGCG
-CCCGCACGCGCCCcGAGTGCCTGCCGCT
CCCCACACGCGCCCcGAGTGTCTGCCGCT
-CCCCCCATCCCCCtGTGTGTCTGCTGCT
-CCCATACCACCCCcGTGTGTCTGCTGTT
(b) (a)
(d)
(c)
(e) (f)
G-367A G-161A
SP1 motif SOX17 motif
Fig. 2 Allele- and factor-speciﬁc transcription enhancement and
inhibition in the human PNMT promoter. ClustalW alignment of
orthologous mammalian PNMT promoter motifs, including two
human alleles, three primates, and six other mammals, with (a)
-367 and (b) -161 positions in lowercase. Rat-human alignments
shown with greater than 50% conserved motif in uppercase for (c)
-367 and (d) -161. JASPAR position frequency matrix scoring of
human sequence (boxes) using (e) SP1 on -367 and (f) SOX17 on
-161. Polymorphic position in boldface type. Using the SOX17
JASPAR motif (YWYTGKB), there are an additional 22 nonpoly-
morphic SOX17 sequence matches at 7 of 8 or better stringency in the
ﬁrst 500 bp of proximal promoter. Using a conventional G/C-rich
motif (Sn) consensus, there are an additional ﬁve nonpolymorphic
matches spanning 11–18 bp each (see Fig. 1)
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123-161 G fw: 50-CCCCACTCACCTCCgGTGTGTCTGC
AGCC-30
-161 G rv: 50-GGCTGCAGACACACcGGAGGTGAG
TGGGG-30
-161 A fw: 50-CCCCACTCACCTCCaGTGTGTCTGC
AGCC-30
-161 A rv: 50-GGCTGCAGACACACtGGAGGTGAGT
GGGG-30
Chromatin ImmunoPrecipitation (ChIP)
PC12 cells at 70% conﬂuence grown on 10-cm poly-L-
lysine-coated plates were transiently transfected with 5 lg
promoter haplotype/reporter plasmid DNA 4 h (Bio-Rad
transfectin). Cells were washed with serum-free medium
(DMEM high-glucose), grown 24 h (5% FBS, 10% HS, 1%
PSG), washed with phosphate-buffered saline (PBS), ﬁxed
with 37% formaldehyde, pelleted, and transferred to lysis
buffer for fragmentation of chromatin to nucleosomes by
controlled sonication (11 cycles in a Branson Soniﬁer; 20-s
pulse at 50% amplitude with 1 min cooling). Nucleosomes
were immunoprecipitated with antibodies for EGR1 (Santa
Cruz Biotechnologies; sc-110x), SP1 (sc-420x), SOX17
(sc-20099x), or IgG/pre-immune serum (‘‘Mock’’; sc-
33608) conjugated to Protein A agarose beads (ChIP Assay
Kit, USB Corporation, Cleveland, OH, USA). After pre-
cipitation, complexes were washed and crosslinking was
reversed at 65C overnight. After column puriﬁcation
(QiaQuick PCR Puriﬁcation, Qiagen), DNA was ampliﬁed
for 26–30 cycles (to preclude signal from the negative
control) with SNP-ﬂanking primers designed using PRI-
MER3, and products were electrophoresed on 1.5% aga-
rose gels and photographed with a digital camera. Primers
were as follows:
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
EGR1           SP1            SOX17      SP1 + SOX17
0.035 0.011 0.014 0.003
p=0.002
p=0.03
p=0.004
p=0.003
Overall
0.034 0.002 0.008 0.9190 G-367A
0.048 0.330 0.029 0.0003 G-161A
0.26 0.33 0.81 0.76 Interaction
ANOVA p-values
p=0.007 p=0.005
p=0.03
p=0.03 p=0.005
Luciferase 3í 5í
-367 -161
(d) Statistics on
trans-activation
(a) PNMT promoter/luciferase reporter design (c) Haplotype trans-activation
G.A A.G A.A G.G G.A A.G A.A G.G G.A A.G A.A G.G G.A A.G A.A G.G
0.5
1.0
1.5
2.0
2.5
G.A A.A A.G G.G
3.0
PNMT promoter haplotype:
G-367A.G-161A
p=0.002
p=0.009
p=0.028
Haplotypes: p=0.009 (overall)
SNPs:
       G-367A: p=0.002
       G-161A: p=0.663
       Interaction: p=0.163
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Fig. 3 SNP-interrupted conserved regulatory motifs in the human
PNMT promoter: functional consequences. a Cartoon of PNMT
promoter/reporter construct, one of four possible promoters based on
variation at positions G-367A/G-161A (G.A, A.G, A.A, G.G), which
were ligated 50 of ﬁreﬂy luciferase in pGL3-Basic plasmid and
transfected into PC12 cells. b Basal (unstimulated) promoter activity
for transfected PNMT promoter haplotypes (G-367A/G-161A; G.A,
A.G, A.A, G.G), measured in cell lysates after 48 h of transient
transfection, mean of four wells ± 1 standard error. Statistics:
Haplotype effect (1-way ANOVA, overall p = 0.009) is shown ﬁrst.
Two-way ANOVA is then shown, factoring by each SNP. Horizontal
bars indicate post-hoc t tests between haplotypes. X axis: Promoter
haplotype; Y axis: Promoter activity in RLU/protein. c Change in
promoter activity for PNMT promoter haplotypes, measured in cell
lysates after 48 h of transient transfection; mean of four wells ± 1
standard error. Y axis shows fold change of activity versus pGL3-
Basic promotorless empty vector, with mock pcDNA3.1 (pCMV)
cotransfection activity subtracted, and normalization by total protein
(quantiﬁed by the Bradford assay). Along the X axis are grouped the
transfected promoter haplotypes (G-367A.G-161A) and the pCMV-
driven transcription factors cotransfected (SP1, EGR1, SOX17, and
SP1 ? SOX17). Horizontal bars indicate post-hoc t tests for haplo-
type comparisons within a cotransfection state. d ANOVA p values
for overall effect, individual SNP effects, and SNP 9 SNP
(G-367A 9 G-161A) interactions, during transcriptional activation
by cotransfection
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123G-367A fw: 50-CTGGGCAAAAGAGGTGAATG-30
G-367A rv: 50-CCTCACCCCCACAATCTTTA-30
G-161A fw: 50-CTGCGGGAGCAAGTACGG-30
G-161A rv: 50-CCCACCCATTCATCCATCT-30
Statistics
Changes in promoter haplotype/reporter activity were
evaluated by one-way or two-way analysis of variance
(ANOVA), as appropriate, using SPSS software (SPSS,
Inc., Chicago, IL, USA), using (as the independent vari-
able) either the haplotype or the SNP. Post-hoc corrections
to signiﬁcance were done by the Fisher LSD (least sig-
niﬁcance difference) method.
Results
SNP-interrupted conserved regulatory motifs in the
PNMT promoter
Alignment of orthologous 1-kb promoters (upstream of the
ATG initiation codon), including three primates, six
mammals, and human reference/variant sequences, showed
a moderately conserved G/C-rich (GGGGGG) motif in
primates, interrupted by the A allele at position -367 in the
human promoter (GCGGG[G/A]GGC; Fig. 2a). In chim-
panzee, bonobo, and rhesus, G occurs at the polymorphic
site; however, in the less conserved region in mouse, rat,
dog, cat, horse, and cow, the allele is A.
At human promoter position -161, G is the major pri-
mate allele (Fig. 2b); however, the surrounding bases are
not well conserved with rodents and nonprimate mammals.
This region of the promoter is divergent across mammals
but conserved within subgroups as clustered by the phy-
logenetic tree in Fig. 2 (mouse and rat, dog and cat, horse
and cow all have pairwise-conserved motifs).
Phylogenetic footprinting was used to predict which
transcription factors are responsible for the allele-speciﬁc
EMSA shifts observed in Fig. 4. Alignments with rat pro-
moter for human sequences ﬂanking promoter positions -
367 (Fig. 2c, human G allele shown) and -161A (Fig. 2d,
human A allele shown) identiﬁed regions with greater than
50% sequence identity (in uppercase). Position frequency
matrix scoring using JASPAR matrices (SP1 on -367 G vs.
A, Fig. 2e; SOX17 on -161 G vs. A, Fig. 2f) highlights
allelic differences: at G-367A, a two-point difference
between alleles, with the -367 G allele scoring higher for
SP1 (88% of maximum score), and at G-161A there was a
30-point difference between alleles, with -161 A scoring
higher on SOX17 (TCC[G/A]GTGTG, 80% of maximum
score). Scoring matrices were selected from the top hits
identiﬁed using CONREAL, with both SP1 and SOX17
mRNA expression in PC12 cells more than 50% of maxi-
mum in GEO proﬁles of PC12 cells.
Allele-speciﬁc transcription: functional enhancement or
inhibition of expression
The transcription factors tested in cotransfection assays
(Fig. 3) were selected by a combination of in silico and in
vitro predictions of regulatory function; at G-367A, G/C-
rich-region candidates SP1 and EGR1 were tested, while at
G-161A, factor SOX17 was evaluated. We compared the
transcriptional response of four PNMT promoter haplo-
types (G-367A.G-161A, illustrated in Fig. 3a) to tran-
scription factors EGR1, SP1, and SOX17. Even though
haplotype G.A did not occur in human samples, creation of
this fourth haplotype (by site-directed mutagenesis)
allowed statistical inferences on each of the two contribu-
tory SNPs, by two-way ANOVA. Graphical and statistical
results are shown in Fig. 3.
Basal haplotype expression
Under basal circumstances, the four haplotypes differed in
transcriptional strength (Fig. 3b) overall (ANOVA
p = 0.009), with a signiﬁcant effect of G-367A
(p = 0.002), but without SNP 9 SNP interaction (two-way
ANOVA p = 0.163). As previously reported (Ji et al.
2005), haplotype G.G was more active than haplotype A.A
(p = 0.009).
G-367A and SP1 or EGR1
We observed a signiﬁcant difference in promoter stimula-
tion (Fig. 3d) between G-367A alleles upon SP1 cotrans-
fection (p = 0.002), with higher activity for the G allele
that displayed a superior SP1 match (Fig. 3c). The response
of the G.A haplotype to SP1 was greater (p = 0.005) than
either of the A.X haplotypes (A.G or A.A). EGR1 trans
activation also differed across PNMT promoter haplotypes
(p = 0.035).
G-161A and SOX17
SOX17 cotransfection produced a modest decline
(p = 0.014) in the activity of each variant haplotype except
G.A (Fig. 3c); there were signiﬁcant differences between
G-161A alleles (p = 0.029) and G-367A alleles (p =
0.008) (Fig. 3d).
Factor cotransfection
In order to further characterize the transcription inhibition
effect of SOX17 on the PNMT promoter, we attempted
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observed an enhanced, supra-additive inhibitory effect
upon transcription (p = 0.003) (Fig. 3c, far right), espe-
cially on G.A and A.A haplotypic backgrounds. We also
observed an allelic difference at G-161A in response to the
factors in combination (SOX17 ? SP1, p = 0.0003), with
lower activity for the A allele.
Allele-speciﬁc factor binding: EMSAs and speciﬁc
antibody disruption
The work described in Figs. 2, 3, 4 reﬂects a cyclical in
silico ? in vitro ? in cella approach to dissecting allele-
speciﬁc transcription regulation by speciﬁc transcription
factors. Allele-speciﬁc shifts of human oligonucleotides
bound to rat chromafﬁn cell nuclear proteins observed in
Fig. 4 prompted the screening for position-weight matrices
scored in Fig. 2. The regulatory effect of these factors is
conﬁrmed in vivo in Fig. 3. However, regulatory stimula-
tion does not guarantee binding of the putative transcrip-
tion factor to a speciﬁc motif. Hence, we select antibodies
based on the combined results to conﬁrm allele-speciﬁc
binding in vitro in an EMSA antibody disruption assay
(Fig. 5).
During EMSA of G-367A (Fig. 4a), the labeled G allele
displayed multiple (2–3) shifts by PC12 nuclear proteins,
which could be partially displaced by the unlabeled G
probe, although not the unlabeled A probe. The labeled A
allele was not shifted by nuclear proteins, indicating
speciﬁcity. Based on the phylogenetic footprinting results
shown in Fig. 2, we tested the effect of antibodies to SP1
(Fig. 5a, lane 3) or EGR1 (lane 4); in each case, the shifted
G-allele bands (lane 2) were disrupted or abolished by
coincubation with the antisera, suggesting involvement of
these two factors. Involvement of EGR1 at G-367A is
further illustrated by Supplementary Fig. 1, pointing out
the overlapping EGR1 motif match, which is superior for
the G allele.
During EMSA of G-161A, we observed multiple elec-
trophoretic mobility shift bands for both labeled alleles
(Fig. 4b, lanes 2 and 6). In each case, the labeled allele
shift is best competed for by the unlabeled A allele
(Fig. 4b, lanes 4 and 7), suggesting higher afﬁnity of the A
allele for the nuclear proteins bound. Based on phyloge-
netic footprinting results shown in Fig. 2, we tested the
effects of an anti-SOX17 antibody on the complex (Fig. 5b,
lane 9); this addition also manifested as a disappearance of
the previously shifted A-allele band (lane 9), once again
suggesting antibody sequestration of nuclear SOX17,
freeing the SOX17 binding site on the -367A allele oli-
gonucleotide. We did not observe such effects at G-161A
using SP1 or mock/IgG antibodies, conﬁrming speciﬁcity
(Fig. 5b, lanes 8 and 10). Furthermore, what appears to be
a G-allele shift (Fig. 5b, lane 2; Fig. 5b, lane 2) was not
displaced by any of the tested antibodies, and hence is of
uncertain signiﬁcance.
Fig. 4 Allele-speciﬁc electrophoretic mobility shifts. Electrophoresis
at 90 V of double-stranded biotinylated oligonucleotides incubating
in the presence/absence of PC12 nuclear DNA-binding protein
extracts (water-soluble) and 1000 9 molar excess unlabeled oligo-
nucleotide. Visualization of bands by trans-blot to nylon membrane,
streptavidin-horseradish-peroxidase conjugation, and incubation for
5 min with luminol solution, followed by exposure on X-ray ﬁlm.
Horizontal black bar separates G- (left) from A- (right) allele
oligonucleotide experiments (label on top of image). Oligonucleotide
sequences designed to match 29-bp motifs at a -367 and b -161, with
polymorphic position in brackets (bottom). Center bar illustrates
migration from top to bottom and highlights G-allele-speciﬁc shift
for -367 oligonucleotide and A-allele-speciﬁc shift for -161
oligonucletotide
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motifs in chromatin
Formation of oligonucleotide-factor-antibody complexes in
vitro is a model but not a substitute for in vivo complex
formation in the cell nucleus. Although the results of the
cotransfection promoter/reporter assays, phylogenetic
footprinting, and electrophoretic mobility shift assays
produce a consistent story of SP1 and EGR1 upregulation
on the G allele at human promoter position -367 and of
SOX17 downregulation on the A allele at position -161, we
attempted to extend this result by chromatin immunopre-
cipitation (ChIP), which may yield insight into endogenous
transcription factor binding by a motif in nuclei prepared
from living cells.
Antibodies to both SP1 and EGR1 immunoprecipitated
nucleosomes harboring the proximal PNMT promoter
(Fig. 6b), as evidenced by the PCR amplicon spanning
G-367A; speciﬁcity was indicated by lack of immunopre-
cipitation by preimmune serum (‘‘Mock’’). Thus, endoge-
nous SP1 and EGR1 seem to interact with the PNMT
proximal promoter within chromatin in vivo, although the
results of this semiquantitative experiment did not distin-
guish differential roles for the G and A alleles.
An antibody to SOX17 also immunoprecipitated nucle-
osomes spanning the PNMT promoter (Fig. 6c), as evi-
denced by the PCR amplicon spanning G-161A, although
the G and A alleles did not differ in band intensity; spec-
iﬁcity was indicated by lack of immunoprecipitation by
preimmune serum (‘‘Mock’’). Once again, lack of differ-
ence for the G and A alleles may simply reﬂect the semi-
quantitative nature of the experiment.
Discussion
Through an integrated in silico ? in vitro ? in cella
approach, we identiﬁed functional allele-speciﬁc tran-
scription factor motifs in the human PNMT promoter,
including the human ortholog of a rat SP1/EGR1 motif
(reviewed in Wong and Tank 2007) and a novel SOX17
motif.
G-367A motif and factors SP1 and EGR1
The G/C-rich SP1 motif is conserved across mammalian
species and disrupted by common human variant G-367A
(GCGGG[G/A]GGC, rs3764351; Fig. 2a), resulting in a
loss of observed binding in EMSA experiments and a
decrease in promoter enhancement in luciferase assays. An
EGR1 motif is also likely in this region (Supplementary
Fig. 1). We conﬁrm regulatory effects of SP1 and EGR1
on this motif in both antibody disruption (Fig. 5) and ChIP
(Fig. 6) experiments. The consistency of the effects across
experiments, backed by extensive mammalian conserva-
tion of the motif, provides evidence supporting a func-
tional polymorphism. Of note for the potential
physiological signiﬁcance of these ﬁndings, SP1 and
Fig. 5 Electrophoretic mobility shifts: Perturbation by transcription
factor-speciﬁc antibodies. Electrophoresis at 90 V of double-stranded
biotinylated oligonucleotides incubate in the presence/absence of
PC12 nuclear DNA-binding protein extracts (water-soluble) and
antibodies to a SP1 and EGR1 versus -367 oligonucleotides or b anti-
SOX17 and anti-SP1 versus -161 oligonucleotides. No-antibody shift
same as Fig. 4 used as a positive control. Nonspeciﬁc (preimmune)
IgG (‘‘Mock’’) was a negative control. Same protocol as Fig. 4
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(GEO database GDS1038 and GDS1039 at http://
www.ncbi.nlm.nih.gov/geo/).
G-161A motif and factor SOX17
At G-161A, a SOX17 motif conserved in primates (Fig. 2)
is disrupted by the variant allele (TCC[G/A]GTGTG,
rs876493), and the downregulatory response of the A allele
at this motif was augmented by SOX17 ? SP1 co-trans-
activation. We documented an effect of SOX17 on the
G-161 motif in both antibody disruption (Fig. 5) and ChIP
(Fig. 6) experiments. SOX17 is also highly expressed in
PC12 chromafﬁn cells (GEO GDS1039).
Perspectives for human trait determination
The signiﬁcance of the results presented here is best under-
stood in the context of the body of linkage and disease
associations already identiﬁed for the PNMT gene. Indeed,
not only is the PNMT locus within the genome-wide conﬁ-
dence interval for linkage with multiple stress traits in
rodents (http://rgd.mcw.edu/), but PNMT promoter allelic
associations occur for several human traits with likely
derangementsinadrenergicfunction,includingthecommon
diseases hypertension (Cui et al. 2003; Rana et al. 2007) and
obesity (Peters et al. 2003). While published single-marker-
on-trait associations for both promoter SNPs exist, the high
degree of linkage disequilibrium (D0 [0.9) between the
SNPs makes it difﬁcult to deﬁnitively ascribe a causal
associationtooneofthetwovariants.UsingthePC12cellas
a model of the human chromafﬁn cell, we were able to show
allele-speciﬁc differences of promoter activity in the pres-
ence of transcription factors SP1, EGR1, and SOX17.
An earlier report on PNMT transcription using a longer
(* 1 kb) transfected human promoter (Ji et al. 2005)
found similar rank-order activities of the two most com-
mon PNMT promoter haplotypes (G.G[A.A; p\0.002),
but no signiﬁcant differences from G.G for the other hap-
lotypes (p[0.05) in PC12 (rat pheochromocytoma) and
TE671 (human medulloblastoma) cells; however, that
report did not pursue regulatory motifs at -367/-161. In a
follow-up study, Ji et al. (2008) also explored the effect of
a relatively rare polymorphism in the ﬁrst PNMT intron
(G280A) on plasma epinephrine as well as on PNMT
transcription. Here we focused instead upon the PNMT
proximal promoter, since the bulk of previous clinical
associations implicated this region (Cui et al. 2003; Mann
et al. 2001, 2002; Peters et al. 2003), the LD across locus is
high, and common functional variation may inﬂuence large
numbers of individuals.
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Fig. 6 Haplotype-speciﬁc endogenous transcription factor binding in
the human PNMT promoter. Chromatin ImmunoPrecipitation (ChIP)
assay to determine binding of particular transcription factors to the
motifs in vivo. a Cartoon of primer design and expected PCR
ampliﬁcation fragment size. Primers speciﬁc for ampliﬁcation of
b -367 were used to identify DNA-protein complexes precipitated
with anti-EGR1, anti-SOX17, or nonspeciﬁc IgG (‘‘Mock,’’ preim-
mune serum) antibodies, or raw sonicated DNA (‘‘Input’’) as a
positive control. c Identical experiment testing anti-SOX17 with -161
primers
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